Dev

src/cds-library/CRD-DTR/IPledge/R4/resources/Questionnaire-R4-IPledge.json

@@ -379,7 +379,7 @@
                 },
                 {
                     "linkId": "6.5",
-                    "text": "4. I understand that some patients while taking isotretinoin or soon after stopping isotetrinoin, have become depressed or developed other serious mental problems. Symptoms of depression include sad, anxious or empty mood, irritability, acting on dangerous impulses, anger, loss of pleasure or interest in social or sport activities, sleeping too much or too little, changes in weight or appetite, school or work performance going down, or trouble concentrating. Some patients taking isotretinoin have had thoughts about hurting themselves or putting an end to their own lives (suicidal thoughts). Some people tried to end their own lives, and some people have ended their own lives. There were reports that some of these people did not appear depressed. There have been reports of patients on isotretinoin becoming aggressive or violent. Some people have had other signs of depression while taking isotretinoin (see #7).",
+                    "text": "4. I understand that some patients while taking isotretinoin or soon after stopping isotretinoin, have become depressed or developed other serious mental problems. Symptoms of depression include sad, anxious or empty mood, irritability, acting on dangerous impulses, anger, loss of pleasure or interest in social or sport activities, sleeping too much or too little, changes in weight or appetite, school or work performance going down, or trouble concentrating. Some patients taking isotretinoin have had thoughts about hurting themselves or putting an end to their own lives (suicidal thoughts). Some people tried to end their own lives, and some people have ended their own lives. There were reports that some of these people did not appear depressed. There have been reports of patients on isotretinoin becoming aggressive or violent. Some people have had other signs of depression while taking isotretinoin (see #7).",
                     "type": "boolean",
                     "required": true
                 },

src/cds-library/CRD-DTR/Shared/R4/resources/Questionnaire-R4-PhysicalExam.json

@@ -1,16 +1,16 @@
 {
   "resourceType": "Questionnaire",
   "id": "physical-exam",
-  "name": "Physican Exam Module",
+  "name": "Physical Exam Module",
   "url": "http://hl7.org/fhir/Questionnaire/physical-exam",
   "meta": {
     "profile": [
       "http://hl7.org/fhir/StructureDefinition/cqf-questionnaire",
       "http://hl7.org/fhir/us/davinci-dtr/StructureDefinition/dtr-questionnaire-r4"
     ]
-  },  
+  },
   "status": "draft",
-  "item":[
+  "item": [
     {
       "linkId": "OBJ.PE",
       "code": [
@@ -32,7 +32,7 @@
               "system": "http://loinc.org"
             }
           ],
-          "type": "string",              
+          "type": "string",
           "text": "General Appearance"
         },
         {
@@ -44,7 +44,7 @@
               "system": "http://loinc.org"
             }
           ],
-          "type": "string",              
+          "type": "string",
           "text": "Head and Face"
         },
         {
@@ -104,7 +104,7 @@
               "system": "http://loinc.org"
             }
           ],
-          "type": "string",              
+          "type": "string",
           "text": "Cardiovascular System"
         },
         {
@@ -172,12 +172,12 @@
           "code": [
             {
               "code": "71401-4",
-              "display": "Extremeties",
+              "display": "Extremities",
               "system": "http://loinc.org"
             }
           ],
           "type": "string",
-          "text": "Extremeties"
+          "text": "Extremities"
         },
         {
           "linkId": "PE.14",
@@ -249,5 +249,5 @@
         }
       ]
     }
- ]
-}
+  ]
+}

src/cds-library/CRD-DTR/Shared/R4/resources/Questionnaire-R4-Subjective.json

@@ -9,15 +9,15 @@
       "http://hl7.org/fhir/StructureDefinition/cqf-questionnaire",
       "http://hl7.org/fhir/us/davinci-dtr/StructureDefinition/dtr-questionnaire-r4"
     ]
-  },  
+  },
   "extension": [
     {
       "url": "http://hl7.org/fhir/StructureDefinition/cqf-library",
       "valueCanonical": "http://hl7.org/fhir/us/davinci-dtr/Library/BasicClinicalInfo-prepopulation"
     }
-  ],  
+  ],
   "status": "draft",
-  "item":[
+  "item": [
     {
       "linkId": "SUB",
       "text": "Subjective",
@@ -78,7 +78,7 @@
               "linkId": "MED.1.4",
               "text": "Frequency",
               "type": "open-choice",
-              "answerValueSet":"http://hl7.org/fhir/ValueSet/timing-abbreviation"
+              "answerValueSet": "http://hl7.org/fhir/ValueSet/timing-abbreviation"
             },
             {
               "linkId": "MED.1.5",
@@ -107,9 +107,9 @@
           "text": "Allergy",
           "type": "open-choice",
           "repeats": true,
-          "anwerOption": []
+          "answerOption": []
         }
       ]
     }
   ]
-}
+}

src/cds-library/CRD-DTR/Shared/R4/resources/ValueSet-R4-condition-clinical.json

@@ -53,7 +53,7 @@
         "extension": [
           {
             "url": "http://hl7.org/fhir/StructureDefinition/valueset-definition",
-            "valueString": "The subject is experiencing a re-occurence or repeating of a previously resolved condition, e.g. urinary tract infection, pancreatitis, cholangitis, conjunctivitis."
+            "valueString": "The subject is experiencing a re-occurrence or repeating of a previously resolved condition, e.g. urinary tract infection, pancreatitis, cholangitis, conjunctivitis."
           }
         ],
         "system": "http://terminology.hl7.org/CodeSystem/condition-clinical",

src/cds-library/CRD-DTR/Turalio/R4/resources/Questionnaire-R4-Turalio.json

@@ -4,9 +4,7 @@
   "name": "TuralioRemsPatientEnrollment",
   "title": "Turalio Rems Patient Enrollment",
   "status": "draft",
-  "subjectType": [
-    "Patient"
-  ],
+  "subjectType": ["Patient"],
   "date": "2020-05-20",
   "publisher": "Da Vinci DTR",
   "extension": [
@@ -230,7 +228,7 @@
                 "code": "White",
                 "display": "White"
               }
-            }            
+            }
           ]
         },
         {
@@ -466,14 +464,16 @@
               }
             }
           ],
-          "item" : [
+          "item": [
             {
               "linkId": "3.1.1",
               "text": "Laboratory Test",
               "type": "string",
-              "initial": [{
-                "valueString": "AST or SGOT"
-              }],
+              "initial": [
+                {
+                  "valueString": "AST or SGOT"
+                }
+              ],
               "readOnly": true
             },
             {
@@ -524,14 +524,16 @@
               }
             }
           ],
-          "item" : [
+          "item": [
             {
               "linkId": "3.1.1",
               "text": "Laboratory Test",
               "type": "string",
-              "initial": [{
-                "valueString": "ALT or SGPT"
-              }],
+              "initial": [
+                {
+                  "valueString": "ALT or SGPT"
+                }
+              ],
               "readOnly": true
             },
             {
@@ -582,14 +584,16 @@
               }
             }
           ],
-          "item" : [
+          "item": [
             {
               "linkId": "3.1.1",
               "text": "Laboratory Test",
               "type": "string",
-              "initial": [{
-                "valueString": "GGT"
-              }],
+              "initial": [
+                {
+                  "valueString": "GGT"
+                }
+              ],
               "readOnly": true
             },
             {
@@ -640,14 +644,16 @@
               }
             }
           ],
-          "item" : [
+          "item": [
             {
               "linkId": "3.1.1",
               "text": "Laboratory Test",
               "type": "string",
-              "initial": [{
-                "valueString": "Total Bilirubin"
-              }],
+              "initial": [
+                {
+                  "valueString": "Total Bilirubin"
+                }
+              ],
               "readOnly": true
             },
             {
@@ -698,14 +704,16 @@
               }
             }
           ],
-          "item" : [
+          "item": [
             {
               "linkId": "3.1.1",
               "text": "Laboratory Test",
               "type": "string",
-              "initial": [{
-                "valueString": "Direct Bilirubin"
-              }],
+              "initial": [
+                {
+                  "valueString": "Direct Bilirubin"
+                }
+              ],
               "readOnly": true
             },
             {
@@ -756,14 +764,16 @@
               }
             }
           ],
-          "item" : [
+          "item": [
             {
               "linkId": "3.1.1",
               "text": "Laboratory Test",
               "type": "string",
-              "initial": [{
-                "valueString": "Alkaline Phosphatase"
-              }],
+              "initial": [
+                {
+                  "valueString": "Alkaline Phosphatase"
+                }
+              ],
               "readOnly": true
             },
             {
@@ -814,14 +824,16 @@
               }
             }
           ],
-          "item" : [
+          "item": [
             {
               "linkId": "3.1.1",
               "text": "Laboratory Test",
               "type": "string",
-              "initial": [{
-                "valueString": "Albumin"
-              }],
+              "initial": [
+                {
+                  "valueString": "Albumin"
+                }
+              ],
               "readOnly": true
             },
             {
@@ -872,14 +884,16 @@
               }
             }
           ],
-          "item" : [
+          "item": [
             {
               "linkId": "3.1.1",
               "text": "Laboratory Test",
               "type": "string",
-              "initial": [{
-                "valueString": "PT/INR"
-              }],
+              "initial": [
+                {
+                  "valueString": "PT/INR"
+                }
+              ],
               "readOnly": true
             },
             {
@@ -1169,4 +1183,4 @@
       ]
     }
   ]
-}
+}

src/config.ts

@@ -3,12 +3,12 @@ import 'dotenv/config';
 import * as env from 'env-var';
 
 // Set up whitelist
-const whitelist_env = env.get('WHITELIST').asArray() || false;
+const whitelistEnv = env.get('WHITELIST').asArray() || false;
 
-// If no whitelist is present, disable cors
-// If it's length is 1, set it to a string, so * works
+// If no whitelist is present, disable CORS
+// If its length is 1, set it to a string, so * works
 // If there are multiple, keep them as an array
-const whitelist = whitelist_env && whitelist_env.length === 1 ? whitelist_env[0] : whitelist_env;
+const whitelist = whitelistEnv && whitelistEnv.length === 1 ? whitelistEnv[0] : whitelistEnv;
 export default {
   server: {
     port: env.get('PORT').asInt(),
@@ -115,6 +115,19 @@ export default {
       valueset: {
         service: './src/services/valueset.service.ts',
         versions: [fhirConstants.VERSIONS['4_0_0']]
+      },
+      guidanceresponse: {
+        service: './src/services/guidanceresponse.service.ts',
+        versions: [fhirConstants.VERSIONS['4_0_0']],
+        operation: [
+          {
+            name: 'rems-etasu',
+            route: '/$rems-etasu',
+            method: 'POST',
+            reference:
+              'https://build.fhir.org/ig/HL7/fhir-medication-rems-ig/OperationDefinition-REMS-ETASU.html'
+          }
+        ]
       }
     }
   }